Arcus Biosciences Market Sentiment

Arcus Biosciences Inc

RCUSNYSE

Trade with Public

$19.36

0.261.36%

Últ. Act.: Oct 22, 6:02 PM

$19.36

0.261.36%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

PRO

¿Por qué se mueve?:Arcus Biosciences shares are trading lower after the company announced the ...

Arcus Biosciences Market Sentiment - Benzinga

Arcus Biosciences Market Sentiment

Market sentiment signals for Arcus Biosciences (RCUS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 17.1% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

20 analysts

Options Flow (P/C)

—

Avg Consensus PT

$37

+90.5%

Highest Price Target

$50

+158.3%

Truist Securities

Lowest Price Target

$14

-27.7%

Barclays

Short Interest

17.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	Citigroup	Yigal Nochomovitz—	+158.3%	$45 → $50	Maintained	Buy
Oct 21, 2026	Truist Securities	Supawat Thongthip—	+111.8%	$40 → $41	Maintained	Buy
Oct 21, 2026	Wedbush	Robert Driscoll—	+153.1%	$43 → $49	Maintained	Outperform
Oct 16, 2026	William Blair	Alethia Young—	—	—	Initiate	Outperform
Oct 14, 2026	JP Morgan	Priyanka Grover—	+111.8%	$41	Initiate	Overweight
Sep 30, 2026	Wedbush	Robert Driscoll—	+122.1%	$43 → $43	Maintained	Outperform
Sep 16, 2026	TD Cowen	Tara Bancroft—	—	—	Initiate	Buy
Sep 8, 2026	Truist Securities	Supawat Thongthip—	+106.6%	$35 → $40	Maintained	Buy
Aug 6, 2026	Wells Fargo	Eva Fortea Verdejo—	+34.3%	$23 → $26	Maintained	Equal-Weight
Aug 6, 2026	Wedbush	Robert Driscoll—	+122.1%	$41 → $43	Maintained	Outperform
Jul 20, 2026	HC Wainwright & Co.	Emily Bodnar—	+132.4%	$32 → $45	Maintained	Buy
Jun 4, 2026	LifeSci Capital	Charles Zhu—	+137.6%	$46	Initiate	Outperform
May 18, 2026	Truist Securities	Supawat Thongthip—	+80.8%	$30 → $35	Assumes	Buy
May 11, 2026	Morgan Stanley	Terence Flynn—	+13.6%	$20 → $22	Maintained	Equal-Weight
May 7, 2026	Goldman Sachs	Richard Law—	+75.6%	$30 → $34	Maintained	Buy
Apr 2, 2026	Wedbush	Robert Driscoll—	+111.8%	$37 → $41	Maintained	Outperform
Mar 5, 2026	Citigroup	Yigal Nochomovitz—	+132.4%	$44 → $45	Maintained	Buy
Mar 2, 2026	Leerink Partners	Geoffrey Porges—	+153.1%	$36 → $49	Maintained	Outperform
Mar 2, 2026	HC Wainwright & Co.	Emily Bodnar—	+65.3%	$32 → $32	Maintained	Buy
Feb 12, 2026	Wells Fargo	Eva Fortea Verdejo—	+18.8%	$30 → $23	Downgrade	Overweight→Equal-Weight
Jan 13, 2026	Goldman Sachs	Richard Law—	+44.6%	$16 → $28	Upgrade	Neutral→Buy
Jan 8, 2026	Morgan Stanley	Terence Flynn—	+3.3%	$23 → $20	Downgrade	Overweight→Equal-Weight
Dec 12, 2025	HC Wainwright & Co.	Emily Bodnar—	+65.3%	$28 → $32	Maintained	Buy
Nov 28, 2025	B of A Securities	Jason Zemansky—	+34.3%	$17 → $26	Maintained	Neutral
Oct 30, 2025	Goldman Sachs	Salveen Richter—	-17.4%	$14 → $16	Maintained	Neutral